Back to Search Start Over

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA).

Authors :
Joerger, Markus
Metaxas, Yannis
Zaman, Khalil
Michielin, Olivier
Mach, Nicolas
Bettini, Adrienne
Schmitt, Andreas M.
Cantoni, Nathan
Caspar, Clemens B.
Stettler, Sonja
Malval, Roma
Pless, Miklos
Britschgi, Christian
Renner, Christoph
Koeberle, Dieter
Schulz, Jessica D.
Kopp, Christoph
Hayoz, Stefanie
Stathis, Anastasios
von Moos, Roger
Source :
Cancers; May2022, Vol. 14 Issue 9, pN.PAG-N.PAG, 12p
Publication Year :
2022

Abstract

Simple Summary: The characterization of clinical outcomes and prognostic factors in COVID-19-infected cancer patients is important for health care authorities, policy makers and oncologists. We collected extensive data on COVID-19-infected cancer patients from 1 March 2020 over a one-year period. Among 455 patients included, death from COVID-19 infection occurred in 98 patients, resulting in a mortality rate of 21.5%. Age ≥ 65 years, non-curative disease, intensive care unit admission and oxygen requirement were particular and independent negative prognostic factors for death from COVID-19. COVID-19 severity and mortality in cancer patients remained high in a country (Switzerland) with a decentralized, high-quality, universal-acess health care system. Purpose: These are the final results of a national registry on cancer patients with COVID-19 in Switzerland. Methods: We collected data on symptomatic COVID-19-infected cancer patients from 23 Swiss sites over a one-year period starting on 1 March 2020. The main objective was to assess the outcome (i.e., mortality, rate of hospitalization, ICU admission) of COVID-19 infection in cancer patients; the main secondary objective was to define prognostic factors. Results: From 455 patients included, 205 patients (45%) had non-curative disease, 241 patients (53%) were hospitalized for COVID-19, 213 (47%) required oxygen, 43 (9%) invasive ventilation and 62 (14%) were admitted to the ICU. Death from COVID-19 infection occurred in 98 patients, resulting in a mortality rate of 21.5%. Age ≥65 years versus <65 years (OR 3.14, p = 0.003), non-curative versus curative disease (OR 2.42, p = 0.012), ICU admission (OR 4.45, p < 0.001) and oxygen requirement (OR 20.28, p < 0.001) were independently associated with increased mortality. Conclusions: We confirmed high COVID-19 severity and mortality in real-world cancer patients during the first and second wave of the pandemic in a country with a decentralized, high-quality, universal-access health care system. COVID-19-associated mortality was particularly high for those of older age in a non-curative disease setting, requiring oxygen or ICU care. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20726694
Volume :
14
Issue :
9
Database :
Complementary Index
Journal :
Cancers
Publication Type :
Academic Journal
Accession number :
156849459
Full Text :
https://doi.org/10.3390/cancers14092191